Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 10 Jul 2026. Budget: 600,000 USD. The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providi…
Opportunity overview
- Project name
- Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
- Budget
- 600,000
- Currency
- US Dollar
Summary
Frequently asked questions
What is Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 10 Jul 2026. Budget: 600,000 USD. The purpose of this notice of funding opportunity (NOFO) is to support applications for the Tuberculosis (TB) Research Advancement Centers (TRACs) program. The goal of the TRACs is to develop the next generation of TB researchers and to catalyze multidisciplinary and innovative TB science by providi…
Who is funding Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is funded by National Institutes of Health.
When is the deadline to apply for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
The application deadline is 10 Jul 2026 00:00 (UTC).
Where will the Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) project take place?
The project location(s) are: United States.
What is the budget for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
The available budget is 600,000 USD.
How can I apply for Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.